Participants in Mindfulness-Based Cognitive Therapy (MBCT) and Mindfulness-Based Stress Reduction (MBSR) complete about 64% of their assigned home mindfulness practice, which amounts to roughly 30 minutes per day, six days per week over eight weeks. Across 43 studies involving 1,427 participants, this estimate varied widely. In 28 studies with 898 participants, there was a small but significant positive association between the amount of self-reported home practice and better intervention outcomes. The findings suggest that while participants do not fully complete assigned practice, the practice they do complete is linked to benefits.
Lysergic acid diethylamide (LSD) shows promise in reducing neuroticism, with a study involving 100 participants revealing a 30% decrease in neurotic traits after psychedelic-assisted therapy. Participants reported enhanced emotional well-being and increased openness, suggesting that psychedelics could be effective tools in psychotherapy techniques for treating neurotic disorders. The findings highlight the potential of chemical synthesis and alkaloids in developing new treatment applications, offering hope for those struggling with neurosis and enhancing the therapeutic arsenal available to psychotherapists.